SB 382-2_ Filed 04/26/2013, 15:38 ChairPerson


COMMITTEE REPORT

    Mr. Speaker: Pursuant to Joint Rule 20, your Committee on Rules and Legislative Procedures, to which was referred Engrossed Senate Bill 382 because it conflicts with SEA 536-2013 AND HEA 1376-2013 without properly recognizing the existence of SEA 536-2013 AND HEA 1376-2013, has had Engrossed Senate Bill 382 under consideration and begs leave to report back to the House with the recommendation that Engrossed Senate Bill 382 be corrected as follows:


    Page 8, line 40, delete "P.L.226-2011," and insert "SEA 536-2013, SECTION 8, AND AS AMENDED BY HEA 1376-2013, SECTION 6,".
    Page 8, line 41, delete "SECTION 15,".
    Page 9, line 18, delete "or".
    Page 9, line 18, after "IC 24-5-14" delete "." and insert ", or IC 24-5- 14.5.".
    Page 10, line 17, delete "and".
    Page 10, line 18, after "receiver" delete "." and insert "; and
        (5) (6) order the department of state revenue to suspend the supplier's registered retail merchant certificate, subject to the requirements and prohibitions contained in IC 6-2.5-8-7(i), if the


        court finds that a violation of this chapter involved the sale or solicited sale of a synthetic drug (as defined in IC 35-31.5-2-321) or a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5).".
    (Reference is to ESB 382 as printed March 26, 2013.)

______________________________________

Representative Torr, Chairperson

______________________________________

Representative Pierce, R.M.M.

______________________________________

Representative Steuerwald, Sponsor


JR 038201/DI 115
2013